Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs ULTA✓SelectedUSD · ULTAGSK vs ULTA performance historyLatest closeAs of-2.32%11/17
Stock and ETF performance explorer

GSK vs ULTA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+57.1%
ULTA return
+56.2%
Excess return
+0.9%
Maximum drawdown
-28.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioULTAExcessAlpha
1D-2.3%-1.8%-0.5%-2.1%
7D-3.0%-3.6%+0.6%-2.6%
30D+0.4%+8.0%-7.7%-0.4%
3M-1.2%+29.8%-31.0%-3.8%
6M+0.9%+29.6%-28.6%-1.8%
YTD+4.0%+5.9%-1.9%+3.0%
1Y+7.3%+25.7%-18.4%+4.6%
3Y+57.1%+56.5%+0.6%+46.8%
All+57.1%+56.2%+0.9%+46.8%

Cumulative growth

Daily Returns

Daily percentage return beside ULTA.

Daily Out/Under-Performance

Portfolio return minus ULTA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × ULTA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded ULTA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling